About Luminex Corporation
Luminex Corporation is a Healthcare company based in Austin (United States) founded in 1995, and was acquired by DiaSorin in April 2021. Developer of instruments, reagents and kits for clinical diagnostics and life science research. The company has 1,004 employees. Luminex Corporation has completed 4 acquisitions, including EraGen Biosciences, Genturadx and Nanosphere. Its website luminexcorp.com draws about 15 thousand monthly visits. Luminex Corporation offers products and services including LIAISON XL, xMAP Technology, and MAGPIX System. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its competitors include Aldevron, Blaze Bioscience and Teknova; 1 of its 3 listed competitors has raised funding.
Company details
Luminex was founded in 1995 in Austin, United States, and operates within the biotechnology sector. Instruments, reagents, and kits are developed for clinical diagnostics and life science research applications. Bead- and tag-based technologies are specialized in for multiplexing immunoassays and nucleic acid assays. Clinical diagnostic solutions are provided for infectious diseases and genetic disorders, supporting operations across research and healthcare domains.
- Headquarters Austin, United States
- Employees 1,004
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website luminexcorp.com
- Social LinkedIn Facebook
- Acquired by DiaSorin (Apr 2021)
- Annual Revenue$417.4 M (USD)25as on Dec 31, 2020
- Net Profit$15.17 M (USD)495as on Dec 31, 2020
- EBITDA$42.44 M (USD)451as on Dec 31, 2020
- Latest Funding Round$11.3M (USD), Grant
Feb 2021
- InvestorsDiaSorin
& 3 more
- Employee Count1,004
- Investments & AcquisitionsEraGen Biosciences
& 3 more
- Acquired byDiaSorin
(Apr 2021)
Products & Services of Luminex Corporation
Luminex Corporation offers a comprehensive portfolio of products and services, including LIAISON XL, xMAP Technology, and MAGPIX System.
Automated system for immunodiagnostic testing of diseases.
Platform for simultaneous biomarker detection in research.
Device for multiplex assays in diagnostics and life sciences.
Funding Insights of Luminex Corporation
- Total Rounds 8
- Last Round Grant — $11.3M
- First Round $100,000
(Feb 2008)
- Investors Count 3
All 8 funding rounds of Luminex Corporation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $11.3M | Grant | – | – | |
| May 2020 | $260M | Post-IPO | – | – | – |
| Mar 2020 | $642,450 | Grant | – | – | |
| Aug 2011 | $3.26M | Grant | – | – | |
| Aug 2011 | $3.26M | Grant | – | – | |
| Jul 2009 | $173,066 | Grant | – | – | |
| Jan 2009 | $100,000 | Grant | – | – | |
| Feb 2008 | $100,000 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Luminex Corporation
Luminex Corporation has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include DiaSorin, Public Health Emergency and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| phe.gov | ||||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
| hhs.gov | ||||
Reagent kits for in vitro diagnostics are developed and commercialized. | 1968 | diasorin.com | Saluggia, Italy |
Investor details for Luminex Corporation
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Luminex Corporation
95 people are tracked at Luminex Corporation (49 in leadership, 1 in board & advisors, 45 in team); the tracked headcount is 1,004.
| Name | Role | Group |
|---|---|---|
Kristie Brok | HR Director Benelux, France, Iberia & LTG EMEA | Leadership |
Josh Glason | Vice President Asia Pacific | Leadership |
Jesse Nergard | Director Of Talent Acquisition, North America | Leadership |
Doug Whitman | Senior Director, Advanced Technology Group At Luminex Corporation, A Diasorin Company | Leadership |
Chen Even | Chief Commercial Officer | Leadership |
Dave Blomberg | Vice President, Sales - Molecular | Leadership |
Amelia Parente | Senior Vice President Corporate HR | Leadership |
Carlo Rosa | CEO | Leadership |
Ralph Michielli | Regional Sales Director | Leadership |
Kristy Hanson | Vice President Of Strategic Accounts | Leadership |
Fabrizio Momblano | Corporate Treasury Director | Leadership |
Leslie Vasquez | Senior Talent Acquisition Partner | Leadership |
Angelo Rago | President, Luminex Corporation | Leadership |
Liana Ryder | Vice President Immuno | Leadership |
Nineveh Sarggis | Senior Director US Commercial Labs East | Leadership |
Fernando Davico | Corporate Vice President Sales Emea, APAC & Latam | Leadership |
Alessandro Pellarin | Corporate VP Commercial Excellence | Leadership |
Joel Cowen | Vice President, Commercial - Immuno | Leadership |
Matteo Pinciroli | Corporate Vice President Market Access | Leadership |
Luca de Rosa | Corporate Director Commercial Business Development | Leadership |
75 more people are available in the full profile.
Complete people profiles for Luminex Corporation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Luminex Corporation
Luminex Corporation has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include EraGen Biosciences, Genturadx and Nanosphere.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diagnostic tests for personalized medicine targeting infections are provided. | nanosphere.us | Northbrook, United States | 1999 | May 2016 | •••• | |
Molecular diagnostic platforms for clinical PCR analysis are developed. | genturadx.com | Hayward, United States | 2005 | Jul 2012 | $50M | |
Molecular reagents and diagnostic assays for disease detection are developed. | eragen.com | Madison, United States | 1994 | Jun 2011 | $34M | |
DNA-based tests for genetic disorders, drug metabolism and infectious diseases | tmbioscience.com | Toronto, Canada | 1992 | Dec 2006 | •••• |
Complete acquisition details for Luminex Corporation
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Luminex Corporation
9 dated milestones of Luminex Corporation across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Luminex Corporation is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Tm Bioscience.
- Funding First funding round of $100K.
- Acquisition Acquires EraGen Biosciences.
- Acquisition Acquires Genturadx.
- Acquisition Acquires Nanosphere.
- Funding Latest funding round, Grant, of $11.3M.
- Exit Acquired by DiaSorin.
Competitors of Luminex Corporation
Luminex Corporation has 3 listed competitors in our database, 1 of them funded. They include Aldevron, Blaze Bioscience and Teknova.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aldevron.com | 1998 | Fargo, United States | 747 | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | ||
| blazebioscience.com | 2010 | Seattle, United States | $123.7M | 27 | Blaze Bioscience is focused on improving cancer patient outcomes. | |
| teknova.com | 1996 | Hollister, United States | 290 | Molecular biology reagents and kits are supplied for research applications. |
Detailed competitors of Luminex Corporation
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Luminex Corporation
The website of Luminex Corporation (luminexcorp.com) receives about 14.9K visits a month and ranks #2,577,696 among all websites worldwide, #3,538 in Biotechnology and Pharmaceuticals.
- Monthly visits14.9K
▲ 196% vs previous month
- Unique visitors1.2K
per month
- Global rank#2,577,696
among all websites
- Category rank#3,538
Health · Biotechnology and Pharmaceuticals
- Bounce rate25%
- Pages per visit5.7
- Average visit5 min 12 sec
- DevicesDesktop 62% · Mobile 38%
Websites whose visitors overlap most with Luminex Corporation. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mylan.com | 100% | 26.4K | #1,585,141 | View details | |
xenotechllc.com | xenotechllc.com | 100% | – | ||
| bd.com | 68% | 1.2M | #57,463 | View details | |
en.wikipedia.org | en.wikipedia.org | 41% | – | ||
finance.yahoo.com | finance.yahoo.com | 39% | #205 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Luminex Corporation
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Luminex Corporation (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Luminex Corporation
Complete news archive for Luminex Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Luminex Corporation
Luminex Corporation was founded in 1995 and raised its 1st funding round 13 years after it was founded.
Luminex Corporation is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Luminex Corporation has 1,004 employees.
Annual revenue of Luminex Corporation is $417.4M as on Dec 31, 2020.
Luminex was founded in 1995 in Austin, United States, and operates within the biotechnology sector. Instruments, reagents, and kits are developed for clinical diagnostics and life science research applications. Bead- and tag-based technologies are specialized in for multiplexing immunoassays and nucleic acid assays. Clinical diagnostic solutions are provided for infectious diseases and genetic disorders, supporting operations across research and healthcare domains.
Luminex Corporation's top competitors include Aldevron, Blaze Bioscience and Teknova.
Luminex Corporation offers LIAISON XL, xMAP Technology, and MAGPIX System.
Luminex Corporation has made 4 acquisitions, including EraGen Biosciences, Genturadx, and Nanosphere.
Luminex Corporation has 4 investors. Key investors include DiaSorin, Public Health Emergency, National Science Foundation, and HHS.
Yes. Luminex Corporation was acquired by DiaSorin in April 2021.